Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.46 |
| ▸ | FABP7 | O15540 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | MDM4 | O15151 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CASP3 | P42574 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25144 | 0.96 | KMT2A (0.49) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL524835 | 0.95 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL525558 | 0.95 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL3976225 | 0.95 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL28036073 | 0.95 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL524545 | 0.95 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL3426738 | 0.95 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL14947096 | 0.92 | KMT2A (0.52) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL1940665 | 0.92 | KMT2A (0.52) | KMT2AFABP5FABP7CA1CA2 | |
| Succinic Acid SCHEMBL28760118 | 0.91 | KMT2A (0.50) | KMT2AFABP5FABP7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115025239-B | PTH prodrugs | 阿森迪斯药物骨疾病股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2025044924-A1 | RADIOPHARMACEUTICAL TARGETING CARBONIC ANHYDRASE | 无锡诺宇医药科技有限公司 | 2025-03-06 | — | — | WO | disclosed |
| CN-119504733-A | Targeted carbonic anhydrase radiopharmaceuticals | 无锡诺宇医药科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-117069670-A | Dimeric compounds targeting PSMA and derivatives and uses thereof | 复旦大学附属华山医院 | 2023-11-17 | — | — | CN | disclosed |
| CN-116970064-A | GLP-1/GCG receptor co-agonists, pharmaceutical compositions comprising same and uses thereof | 苏州星洲生物科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116970063-A | GLP-1/GIP receptor co-agonists, pharmaceutical compositions comprising same and uses thereof | 苏州星洲生物科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-115702026-A | Macrocyclic compounds and methods of use thereof | 基因泰克公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-115279390-A | Reverse amide linked melanotropin receptor specific cyclic peptides | 帕拉丁科技公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-115025239-A | PTH prodrugs | 阿森迪斯药物骨疾病股份有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-109069659-B | PTH prodrugs | 阿森迪斯药物骨疾病股份有限公司 | 2022-04-19 | — | — | CN | disclosed |
| WO-2003092743-A1 | RADIOPHARMACEUTICAL FORMULATIONS | BRACCO IMAGING S.P.A. (IT) | 2003-11-13 | — | — | WO | disclosed |
| US-6482921-B1 | Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use | ESSENTIAL THERAPEUTICS, INC. | 2002-11-19 | — | — | US | disclosed |
| WO-2000044335-A2 | URIDYL PEPTIDE ANTIBIOTIC (UPA) DERIVATIVES, THEIR SYNTHESIS AND USE | MICROCIDE PHARMACEUTICALS, INC. (US) | 2000-08-03 | — | — | WO | disclosed |
| EP-0541663-A1 | PEPTIDES AND PHARMACEUTICAL COMPOSITIONS HAVING GLYCOPROTEIN HORMONE AGONISTIC OR ANTAGONISTIC ACTIVITY | STICHTING CENTRAAL DIERGENEESKUNDIG INSTITUUT (NL) | 1993-05-19 | — | — | EP | disclosed |
| US-5208324-A | Complexes as contrast agents for magnetic resonance imaging | NYCOMED IMAGING AS (NO) | 1993-05-04 | — | — | US | disclosed |
| EP-0396617-B1 | PARAMAGNETIC COMPOUNDS | NYCOMED AS (NO) | 1992-06-24 | — | — | EP | disclosed |
| WO-1992002542-A1 | PEPTIDES AND PHARMACEUTICAL COMPOSITIONS HAVING GLYCOPROTEIN HORMONE AGONISTIC OR ANTAGONISTIC ACTIVITY | STICHTING CENTRAAL DIERGENEESKUNDIG INSTITUUT (NL) | 1992-02-20 | — | — | WO | disclosed |
| EP-0396617-A1 | PARAMAGNETIC COMPOUNDS. | NYCOMED AS (NO) | 1990-11-14 | — | — | EP | disclosed |
| WO-1989006979-A1 | PARAMAGNETIC COMPOUNDS | COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) | 1989-08-10 | — | — | WO | disclosed |
| EP-0326226-A1 | Paramagnetic compounds | NYCOMED AS (NO) | 1989-08-02 | — | — | EP | disclosed |